Sources

13 Total Sources

FDA Approves Rasonque for Metastatic Pancreatic Cancer After Trial Doubled Survival to 13.2 Months

Healthcare Brew64d ago

FDA Approves Revolution Medicines' Daraxonrasib (Rasonque) for Metastatic Pancreatic Cancer

philstockworld.com64d ago

Revolution Medicines' Daraxonrasib Wins FDA Approval as Rasonque: What the RAS Breakthrough Means for RVMD Investors - Phil Stock World

David Gandara on X: "Re- fast FDA approval for daraxonrasib in pancreas cancer, while we are all cheering this fantastic advance, the sobering news is the all time high oral drug price,

The Washington Post64d ago

FDA approves 'landmark' pancreatic cancer drug daraxonrasib - The Washington Post

Cancer Network64d ago

FDA Approves Daraxonrasib for Previously Treated Metastatic Pancreatic Cancer | CancerNetwork

FDA approves daraxonrasib, a new treatment for advanced pancreatic cancer

FDA approves daraxonrasib, a new treatment for advanced pancreatic cancer

Live 5 News WCSC64d ago

FDA approves daraxonrasib, a new treatment for advanced pancreatic cancer

Facebook64d ago

Daraxonrasib approved for metastatic pancreatic adenocarcinoma

linkedin64d ago

FDA Approves Daraxonrasib for Pancreatic Cancer | Yüksel ÜRÜN posted on the topic | LinkedIn

Gulf Coast Media64d ago

FDA approves first-in-class targeted therapy for metastatic pancreatic cancer - Gulf Coast Media

Chemistry World64d ago

US approves pancreatic cancer treatment that targets 'undruggable' proteins | Business | Chemistry World

FDA approved a revolutionary cancer drug. Insurance wasn't ready